Remove 2019 Remove Assay Development Remove Disease Remove Pharmacokinetics
article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

Cancer is a complex heterogenous multistep disease characterised by uncontrolled cell proliferation combined with a dysregulated immune response. The number of new cases recorded between 2016 and 2018 was 375,400, with 167,142 deaths caused by cancer between 2017 and 2019.

Research 130
article thumbnail

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Agency IQ

after ischemic heart disease and stroke. In 2019 more than one in four (28%) of deaths in the E.U. The current update expands the discussion on biomarker-guided therapeutic development and recent oncology study designs, in addition to a variety of less consequential updates throughout. were from cancer.